Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-01-18 to 2023-01-30
Current total value of award: $1067.08
Description: 8509647531!TYPHOID VI POLYSACC